Who owns UNICYCIVE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Unicycive Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Unicycive Therapeutics stock

Who bought or sold UNICYCIVE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BVF 3.6M $5.0M 71% Mar 2024
 View chart
RA Capital Management 3.5M $4.8M 0% Mar 2024
 View chart
Vivo Capital 3.5M $4.8M 0% Mar 2024
 View chart
Logos Global Management 3.5M $3.0M 100% Mar 2024
 View chart
Nantahala Capital Management 3.3M $8.6M -3% Mar 2024
 View chart
Rosalind Advisors 1.9M $2.6M 100% Mar 2024
 View chart
Monashee Investment Management 1.0M $1.4M 100% Mar 2024
 View chart
Vanguard Group 340k $469k 195% Mar 2024
 View chart
Geode Capital Management 253k $349k 383% Mar 2024
 View chart
Goldman Sachs Group 93k $129k 0% Mar 2024
 View chart
Citadel Advisors 69k $96k 96% Mar 2024
 View chart
Virtu Financial 26k $36k 100% Mar 2024
 View chart
Northern Trust 24k $33k 100% Mar 2024
 View chart
Captrust Financial Advisors 19k $26k 0% Mar 2024
 View chart
Tandem Capital Management Corp 16k $21k 0% Mar 2024
 View chart
Integrated Wealth Concepts 10k $14k 100% Mar 2024
 View chart
Tower Research Capital 7.7k $11k 150% Mar 2024
 View chart
UBS Group 4.4k $6.1k 2393% Mar 2024
 View chart
Wells Fargo & Company 196.00 $270.009600 2% Mar 2024
 View chart
Jpmorgan Chase & Co 47.00 $65.001000 100% Mar 2024
 View chart

Who sold out of Unicycive Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Beacon Pointe Advisors Sep 2023 12k $10k